Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients

PURPOSE: Treatment and clinical-outcomes were described in a sub-cohort of non-small-cell lung cancer (NSCLC) patients with disease-progression (PD) after epidermal growth factor tyrosine kinase inhibitors (EGFR-TKIs) treatment. PATIENTS AND METHODS: We retrospectively analyzed a single-institutiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Tudor, Roxana Alina, D'Silva, Adrijana, Tremblay, Alain, MacEachern, Paul, Morris, Don, Brenner, Darren, Kopciuk, Karen, Bebb, Dafydd Gwyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544231/
https://www.ncbi.nlm.nih.gov/pubmed/28777825
http://dx.doi.org/10.1371/journal.pone.0181867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544231/
https://www.ncbi.nlm.nih.gov/pubmed/28777825
http://dx.doi.org/10.1371/journal.pone.0181867

Ejemplares similares